NCT01786902View on ClinicalTrials.gov

Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

PHASE3CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Idiopathic Short Stature

Interventions

DRUG

DA-3002

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01786902 - Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature | Biotech Hunter | Biotech Hunter